IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,348 | -36.3% | 19,870 | -29.6% | 0.04% | -53.4% |
| Q2 2023 | $300,261 | +6.7% | 28,220 | +5.5% | 0.09% | -2.2% |
| Q1 2023 | $281,410 | -14.3% | 26,750 | +1.0% | 0.09% | -17.4% |
| Q4 2022 | $328,298 | +35.7% | 26,497 | +13.3% | 0.11% | -8.4% |
| Q3 2022 | $242,000 | +8.0% | 23,387 | +20.5% | 0.12% | -14.4% |
| Q2 2022 | $224,000 | +23.1% | 19,409 | +33.8% | 0.14% | +52.7% |
| Q1 2022 | $182,000 | +15.2% | 14,504 | +7.4% | 0.09% | +24.7% |
| Q4 2021 | $158,000 | +364.7% | 13,503 | +422.6% | 0.07% | +231.8% |
| Q3 2021 | $34,000 | -50.0% | 2,584 | -51.4% | 0.02% | -48.8% |
| Q2 2021 | $68,000 | +223.8% | 5,316 | +183.2% | 0.04% | +26.5% |
| Q1 2021 | $21,000 | – | 1,877 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |